Indaptus Therapeutics, Inc. (INDP) SEC filings
INDP SEC filings moved a median of -1.28% by the close. INDP SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the INDP overview →
98 measured INDP SEC filing events.
Where these INDP SEC filings landedvs 98 measured INDP SEC filing reactions
| Middle 50% of INDP SEC filing reactions | -6.39% to +4.01% |
|---|---|
| Median reaction (to close) | -1.28% |
| Measured reactions | 98 |
Point-in-time · zero look-ahead
Half of the 98 INDP SEC filing events with a measured close landed between -6.39% and +4.01%; 44% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form S-8 Indaptus Therapeutics, | SEC filing · Form S-8 | -3.19% | +3.19% | |
| Form 8-K Indaptus Therapeutics, For: Sep 29 | SEC filing · Form 8-K | -5.79% | -19.86% | |
| Form 8-K Indaptus Therapeutics, For: Sep 08 | SEC filing · Form 8-K | +5.08% | +28.00% | |
| Form 8-K/A Indaptus Therapeutics, For: Aug 28 | SEC filing · Form 8-K | +3.10% | +43.41% | |
| Form 8-K Indaptus Therapeutics, For: Sep 02 | SEC filing · Form 8-K | +3.10% | +43.41% | |
| Form 8-K Indaptus Therapeutics, For: Aug 28 | SEC filing · Form 8-K | +1.36% | +2.73% | |
| Form EFFECT Indaptus Therapeutics, | SEC filing · Form EFFECT | +4.13% | +4.59% | |
| Form S-3 Indaptus Therapeutics, | SEC filing · Form S-3 | -7.00% | -6.39% | |
| Form 10-Q Indaptus Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +3.92% | +3.92% | |
| Form 8-K Indaptus Therapeutics, For: Aug 10 | SEC filing · Form 8-K | +3.92% | +3.92% | |
| Form EFFECT Indaptus Therapeutics, | SEC filing · Form EFFECT | +0.00% | -1.60% | |
| Form DEF 14A Indaptus Therapeutics, For: Jul 16 | SEC filing · Form DEF | — | +2.85% | |
| Form S-3 Indaptus Therapeutics, | SEC filing · Form S-3 | +1.76% | -10.26% | |
| Form 8-K Indaptus Therapeutics, For: Jun 17 | SEC filing · Form 8-K | -2.23% | -8.94% | |
| Form PRE 14A Indaptus Therapeutics, For: Jun 22 | SEC filing · Form PRE | +2.22% | +3.06% | |
| Form 8-K Indaptus Therapeutics, For: Jun 01 | SEC filing · Form 8-K | +10.23% | -40.34% | |
| Form 10-Q Indaptus Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | — | -9.66% | |
| Form 8-K Indaptus Therapeutics, For: May 15 | SEC filing · Form 8-K | — | -9.66% | |
| Form 8-K/A Indaptus Therapeutics, For: Apr 22 | SEC filing · Form 8-K | +3.13% | +7.19% | |
| Form 8-K Indaptus Therapeutics, For: Apr 22 | SEC filing · Form 8-K | — | -7.08% | |
| Form 8-K Indaptus Therapeutics, For: Mar 31 | SEC filing · Form 8-K | -0.61% | +7.36% | |
| Form 8-K Indaptus Therapeutics, For: Mar 18 | SEC filing · Form 8-K | +0.00% | +3.53% | |
| Form 10-K Indaptus Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -8.54% | -6.03% | |
| Form 8-K Indaptus Therapeutics, For: Feb 26 | SEC filing · Form 8-K | — | +7.14% | |
| Form 8-K Indaptus Therapeutics, For: Feb 11 | SEC filing · Form 8-K | -6.76% | -6.78% | |
| Form DEFA14A Indaptus Therapeutics, | SEC filing · Form DEFA14A | -6.76% | -6.78% | |
| Form DEF 14A Indaptus Therapeutics, For: Jan 21 | SEC filing · Form DEF | — | +5.32% | |
| Form 8-K Indaptus Therapeutics, For: Jan 20 | SEC filing · Form 8-K | +0.87% | -7.99% | |
| Form 8-K Indaptus Therapeutics, For: Jan 08 | SEC filing · Form 8-K | -1.67% | +5.03% | |
| Form PRE 14A Indaptus Therapeutics, For: Dec 31 | SEC filing · Form PRE | -1.67% | +5.03% | |
| Form 8-K Indaptus Therapeutics, For: Dec 29 | SEC filing · Form 8-K | -0.38% | -4.54% | |
| Form 8-K Indaptus Therapeutics, For: Dec 22 | SEC filing · Form 8-K | -3.34% | -11.37% | |
| Form 10-Q Indaptus Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +6.97% | +5.86% | |
| Form 8-K Indaptus Therapeutics, For: Nov 12 | SEC filing · Form 8-K | +6.97% | +5.86% | |
| Form 8-K Indaptus Therapeutics, For: Sep 04 | SEC filing · Form 8-K | +0.66% | -17.43% | |
| Form S-1/A Indaptus Therapeutics, | SEC filing · Form S-1 | -2.62% | -5.59% | |
| Form S-1 Indaptus Therapeutics, | SEC filing · Form S-1 | +0.00% | -2.18% | |
| Form EFFECT Indaptus Therapeutics, | SEC filing · Form EFFECT | -1.51% | -1.38% | |
| Form 10-Q Indaptus Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -1.66% | +7.79% | |
| Form 8-K Indaptus Therapeutics, For: Aug 13 | SEC filing · Form 8-K | -1.66% | +7.79% | |
| Form S-3 Indaptus Therapeutics, | SEC filing · Form S-3 | +2.69% | -1.76% | |
| Form 8-K Indaptus Therapeutics, For: Jul 25 | SEC filing · Form 8-K | +0.00% | -5.47% | |
| Form 8-K Indaptus Therapeutics, For: Jul 14 | SEC filing · Form 8-K | -4.25% | -7.52% | |
| Form 8-K Indaptus Therapeutics, For: Jun 30 | SEC filing · Form 8-K | +4.33% | +17.86% | |
| Form 8-K Indaptus Therapeutics, For: Jun 25 | SEC filing · Form 8-K | -0.89% | -6.21% | |
| Form DEF 14A Indaptus Therapeutics, For: Jun 23 | SEC filing · Form DEF | -2.20% | +10.12% | |
| Form D Indaptus Therapeutics, | SEC filing · Form D | +7.04% | -10.01% | |
| Form 8-K Indaptus Therapeutics, For: Jun 12 | SEC filing · Form 8-K | -5.63% | -1.25% | |
| Form PRE 14A Indaptus Therapeutics, For: Jun 13 | SEC filing · Form PRE | +1.52% | +0.62% | |
| Form 8-K Indaptus Therapeutics, For: Jun 10 | SEC filing · Form 8-K | +0.93% | +5.31% | |
| Form 10-Q Indaptus Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -3.53% | -9.87% | |
| Form 8-K Indaptus Therapeutics, For: May 14 | SEC filing · Form 8-K | -3.53% | -9.87% | |
| Form ARS Indaptus Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.00% | +1.58% | |
| Form DEF 14A Indaptus Therapeutics, For: Apr 28 | SEC filing · Form DEF | +0.00% | +1.58% | |
| Form DEFA14A Indaptus Therapeutics, | SEC filing · Form DEFA14A | +0.00% | +1.58% | |
| Form PRE 14A Indaptus Therapeutics, For: Dec 31 | SEC filing · Form PRE | +0.00% | -3.15% | |
| Form EFFECT Indaptus Therapeutics, | SEC filing · Form EFFECT | -0.01% | +1.90% | |
| Form 10-K Indaptus Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -1.85% | |
| Form 8-K Indaptus Therapeutics, For: Mar 13 | SEC filing · Form 8-K | +0.00% | -1.85% | |
| Form POS AM Indaptus Therapeutics, | SEC filing · Form POS | +0.00% | -1.85% | |
| Form EFFECT Indaptus Therapeutics, | SEC filing · Form EFFECT | +1.82% | +4.04% | |
| Form 8-K Indaptus Therapeutics, For: Feb 12 | SEC filing · Form 8-K | +0.00% | -6.55% | |
| Form EFFECT Indaptus Therapeutics, | SEC filing · Form EFFECT | +0.00% | -6.55% | |
| Form S-1 Indaptus Therapeutics, | SEC filing · Form S-1 | — | -6.39% | |
| Form S-3 Indaptus Therapeutics, | SEC filing · Form S-3 | -0.63% | -0.40% | |
| Form 8-K Indaptus Therapeutics, For: Jan 31 | SEC filing · Form 8-K | +0.00% | +3.71% | |
| Form D Indaptus Therapeutics, | SEC filing · Form D | — | -2.62% | |
| Form 8-K Indaptus Therapeutics, For: Jan 12 | SEC filing · Form 8-K | -4.25% | -7.45% | |
| Form EFFECT Indaptus Therapeutics, | SEC filing · Form EFFECT | +0.00% | +4.12% | |
| Form S-1 Indaptus Therapeutics, | SEC filing · Form S-1 | +0.00% | -0.08% | |
| Form D Indaptus Therapeutics, | SEC filing · Form D | -0.94% | -5.66% | |
| Form 8-K Indaptus Therapeutics, For: Nov 22 | SEC filing · Form 8-K | +9.44% | +7.36% | |
| Form 10-Q Indaptus Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | — | +0.88% | |
| Form 8-K Indaptus Therapeutics, For: Nov 12 | SEC filing · Form 8-K | +0.00% | +0.88% | |
| Form 8-K Indaptus Therapeutics, For: Oct 17 | SEC filing · Form 8-K | +14.10% | +22.27% | |
| Form D/A Indaptus Therapeutics, | SEC filing · Form D | +0.00% | +7.27% | |
| Form EFFECT Indaptus Therapeutics, | SEC filing · Form EFFECT | +0.00% | -13.51% | |
| Form S-1 Indaptus Therapeutics, | SEC filing · Form S-1 | — | -1.31% | |
| Form D Indaptus Therapeutics, | SEC filing · Form D | — | -3.05% | |
| Form 10-Q Indaptus Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -2.29% | |
| Form 8-K Indaptus Therapeutics, For: Aug 12 | SEC filing · Form 8-K | +0.00% | -2.29% | |
| Form S-8 Indaptus Therapeutics, | SEC filing · Form S-8 | +0.00% | -2.29% | |
| Form 8-K Indaptus Therapeutics, For: Aug 07 | SEC filing · Form 8-K | +0.00% | -1.14% | |
| Form 8-K Indaptus Therapeutics, For: Jun 06 | SEC filing · Form 8-K | — | -8.27% | |
| Form 8-K Indaptus Therapeutics, For: May 22 | SEC filing · Form 8-K | -5.60% | -7.46% | |
| Form 10-Q Indaptus Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | — | +0.98% | |
| Form 8-K Indaptus Therapeutics, For: May 08 | SEC filing · Form 8-K | — | +0.98% | |
| Form DEF 14A Indaptus Therapeutics, For: Apr 26 | SEC filing · Form DEF | -2.70% | -4.96% | |
| Form DEFA14A Indaptus Therapeutics, | SEC filing · Form DEFA14A | -2.70% | -4.96% | |
| Form 8-K Indaptus Therapeutics, For: Mar 25 | SEC filing · Form 8-K | +9.07% | +15.35% | |
| Form 10-K Indaptus Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -2.49% | -0.50% | |
| Form 8-K Indaptus Therapeutics, For: Mar 13 | SEC filing · Form 8-K | -2.49% | -0.50% | |
| Form 8-K Indaptus Therapeutics, For: Mar 04 | SEC filing · Form 8-K | +0.91% | +6.79% | |
| Form 8-K Indaptus Therapeutics, For: Jan 22 | SEC filing · Form 8-K | — | +1.55% | |
| Form 10-Q Indaptus Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +1.41% | -15.14% | |
| Form 8-K Indaptus Therapeutics, For: Nov 04 | SEC filing · Form 8-K | +0.00% | -5.96% | |
| Form 8-K Indaptus Therapeutics, For: Nov 06 | SEC filing · Form 8-K | +1.41% | -15.14% | |
| Form 8-K Indaptus Therapeutics, For: Oct 31 | SEC filing · Form 8-K | — | +8.41% |
Keep exploring
More INDP: earnings → · analyst actions → · INDP overview →